CoChat

Mis-spliced transcripts generate de novo proteins in TDP-43–related ALS/FTD

Open access
Seddighi, Sahba, Qi, Yue A., Brown, Anna-Leigh, Wilkins, Oscar G., Bereda, Colleen, Belair, Cedric, Zhang, Yong-Jie, Prudencio, Mercedes, Keuss, Matthew J., Khandeshi, Aditya, Pickles, Sarah, Kargbo-Hill, Sarah E., Hawrot, James, Ramos, Daniel M., Yuan, Hebao, Roberts, Jessica, Sacramento, Erika Kelmer, Shah, Syed I., Nalls, Mike A., Colón-Mercado, Jennifer M., Reyes, Joel F., Ryan, Veronica H., Nelson, Matthew P., Cook, Casey N., Li, Ziyi, Screven, Laurel, Kwan, Justin Y., Mehta, Puja R., Zanovello, Matteo, Hallegger, Martina, Shantaraman, Anantharaman, Ping, Lingyan, Koike, Yuka, Oskarsson, Björn, Staff, Nathan P., Duong, Duc M., Ahmed, Aisha, Secrier, Maria, Ule, Jernej, Jacobson, Steven, Reich, Daniel S., Rohrer, Jonathan D., Malaspina, Andrea, Dickson, Dennis W., Glass, Jonathan D., Ori, Alessandro, Seyfried, Nicholas T., Maragkakis, Manolis, Petrucelli, Leonard, Fratta, Pietro, Ward, Michael E. · 2024 · Science Translational Medicine
Cited by 188

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

Functional loss of TDP-43, an RNA binding protein genetically and pathologically linked to amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), leads to the inclusion of cryptic exons in hundreds of transcripts during disease. Cryptic exons can promote the degradation of affected transcripts, deleteriously altering cellular function through loss-of-function mechanisms. Here, we show that mRNA transcripts harboring cryptic exons generated de novo proteins in TDP-43–depleted human iPSC–derived neurons in vitro, and de novo peptides were found in cerebrospinal fluid (CSF) samples from patients with ALS or FTD. Using coordinated transcriptomic and proteomic studies of TDP-43–depleted human iPSC–derived neurons, we identified 65 peptides that mapped to 12 cryptic exons. Cryptic exons identified in TDP-43–depleted human iPSC–derived neurons were predictive of cryptic exons expressed in postmortem brain tissue from patients with TDP-43 proteinopathy. These cryptic exons produced transcript variants that generated de novo proteins. We found that the inclusion of cryptic peptide sequences in proteins altered their interactions with other proteins, thereby likely altering their function. Last, we showed that 18 de novo peptides across 13 genes were present in CSF samples from patients with ALS/FTD spectrum disorders. The demonstration of cryptic exon translation suggests new mechanisms for ALS/FTD pathophysiology downstream of TDP-43 dysfunction and may provide a potential strategy to assay TDP-43 function in patient CSF.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.adg7162

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 188

Metadata

Authors
Seddighi, S., Qi, Y. A., Brown, A.-L., Wilkins, O. G., Bereda, C., Belair, C., Zhang, Y.-J., Prudencio, M., Keuss, M. J., Khandeshi, A., Pickles, S., Kargbo-Hill, S. E., Hawrot, J., Ramos, D. M., Yuan, H., Roberts, J., Sacramento, E. K., Shah, S. I., Nalls, M. A., Colón-Mercado, J. M., Reyes, J. F., Ryan, V. H., Nelson, M. P., Cook, C. N., Li, Z., Screven, L., Kwan, J. Y., Mehta, P. R., Zanovello, M., Hallegger, M., Shantaraman, A., Ping, L., Koike, Y., Oskarsson, B., Staff, N. P., Duong, D. M., Ahmed, A., Secrier, M., Ule, J., Jacobson, S., Reich, D. S., Rohrer, J. D., Malaspina, A., Dickson, D. W., Glass, J. D., Ori, A., Seyfried, N. T., Maragkakis, M., Petrucelli, L., Fratta, P., & Ward, M. E.
Venue
Science Translational Medicine
Published
2024-02-14
Volume
16
Issue
734
Pages
eadg7162-eadg7162
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W4391249056
Cited by
188
References
35
FWCI
42.15
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.